Arbutus Biopharma Corporation P/E Ratio 2011-2026 | ABUS

Annual P/E Ratio Arbutus Biopharma Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-25.3	-11.7	-6.11	-6.06	-5.42	-4.71	-1.04	-3.6	-3.3	-0.352	-2.34	-14.8	-14.1	2.21	-2.5

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.21	-25.3	-6.61

P/E Ratio of other stocks in the Biotechnology industry

Issuer	P/E Ratio	Price	% 24h	Market Cap	Country
Aligos Therapeutics ALGS	-2.73	$ 7.92	-0.94 %	$ 78.3 M	USA
MorphoSys AG MOR	-0.612	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	-66.5	$ 3.63	-2.42 %	$ 8.73 B	Australia
I-Mab IMAB	-0.236	-	-	$ 866 M	China
AlloVir ALVR	-0.189	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	-0.175	-	-	$ 10.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	55.7	-	-	$ 40.3 B	USA
Genfit SA GNFT	2.49 K	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-17.6	-	-13.47 %	$ 169 M	France
Applied Therapeutics APLT	-4.52	-	-	$ 8.42 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	-3.57	-	-1.52 %	$ 24.7 M	USA
Precision BioSciences DTIL	-0.813	$ 6.73	0.9 %	$ 25.9 M	USA
Midatech Pharma plc MTP	-14.5	-	-18.52 %	$ 27.3 M	Britain
Esperion Therapeutics ESPR	-24.7	$ 2.15	-0.69 %	$ 447 M	USA
Evogene Ltd. EVGN	-2.18	$ 0.81	-0.33 %	$ 27.9 M	Israel
BioNTech SE BNTX	6.11	$ 97.86	2.47 %	$ 27.2 B	Germany
Amphastar Pharmaceuticals AMPH	12.7	$ 20.29	-0.39 %	$ 948 M	USA
Galectin Therapeutics GALT	-5.78	$ 2.42	5.22 %	$ 155 M	USA
Genmab A/S GMAB	33.2	$ 28.24	-0.04 %	$ 18 B	Danmark
Acorda Therapeutics ACOR	-0.0662	-	-24.86 %	$ 820 K	USA
Институт стволовых клеток человека ISKJ	38.8	-	-	-	Russia
Adverum Biotechnologies ADVM	-0.583	-	-	$ 86.2 M	USA
Grifols, S.A. GRFS	31.7	$ 8.14	-0.85 %	$ 6.83 B	Spain
Advaxis ADXS	-0.0388	-	-9.65 %	$ 45.9 M	USA
GT Biopharma GTBP	-0.0914	$ 0.36	-3.5 %	$ 1.98 M	USA
Halozyme Therapeutics HALO	30.5	$ 67.79	-0.05 %	$ 8.12 B	USA
Aeterna Zentaris AEZS	-4.94	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-0.00095	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-3.48	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	-62.5	$ 1.42	1.07 %	$ 365 M	USA
Applied Genetic Technologies Corporation AGTC	-1.71	-	-	$ 26.5 M	USA
Allakos ALLK	-0.612	-	-	$ 28.6 M	USA
Can-Fite BioPharma Ltd. CANF	-0.489	$ 2.96	1.37 %	$ 4.87 M	Israel
Aptinyx APTX	-0.146	-	-39.0 %	$ 4.57 M	USA
Aquestive Therapeutics AQST	-5.58	$ 4.15	1.72 %	$ 444 M	USA
Aravive ARAV	-0.791	-	-13.39 %	$ 1.45 M	USA
Arcutis Biotherapeutics ARQT	-213	$ 24.3	0.37 %	$ 3.09 B	USA
Harmony Biosciences Holdings HRMY	10.1	$ 28.82	-0.24 %	$ 1.66 B	USA
AIkido Pharma AIKI	-1.33	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	-7.88	$ 32.37	0.4 %	$ 2.15 B	USA
Autolus Therapeutics plc AUTL	-1.12	$ 1.52	1.68 %	$ 405 M	Britain
Aptose Biosciences APTO	-0.0913	-	-45.71 %	$ 1.2 M	Canada
Cidara Therapeutics CDTX	-0.873	-	-	$ 1.41 B	USA
ImmuCell Corporation ICCC	-55.8	$ 7.24	2.33 %	$ 65.3 M	USA
AVROBIO AVRO	4.63	-	1083.1 %	$ 745 M	USA
Immatics N.V. IMTX	-5.39	$ 10.61	1.73 %	$ 668 M	Germany
Incyte Corporation INCY	15.1	$ 96.66	0.61 %	$ 18.9 B	USA
Ayala Pharmaceuticals AYLA	-0.203	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	-1.16	$ 2.58	1.18 %	$ 16.2 M	USA
InflaRx N.V. IFRX	-3.26	$ 1.05	4.95 %	$ 152 M	Germany